Results 281 to 290 of about 491,626 (323)
Some of the next articles are maybe not open access.
Critical Reviews in Oncology/Hematology, 2017
Lymphoblastic lymphoma (LBL) is a neoplasm of immature B cells committed to the B-(B-LBL) or T-cell lineage (T-LBL) that accounts for approximately 2% of all lymphomas. From a histopathological point of view, blasts may be encountered in tissue biopsy and/or bone marrow (BM).
S. Cortelazzo +3 more
semanticscholar +5 more sources
Lymphoblastic lymphoma (LBL) is a neoplasm of immature B cells committed to the B-(B-LBL) or T-cell lineage (T-LBL) that accounts for approximately 2% of all lymphomas. From a histopathological point of view, blasts may be encountered in tissue biopsy and/or bone marrow (BM).
S. Cortelazzo +3 more
semanticscholar +5 more sources
Update on Lymphoblastic Leukemia/Lymphoma.
Clinics in Laboratory Medicine, 2021Lymphoblastic leukemias/lymphomas are predominantly diseases of childhood, where they represent almost all acute leukemias; however, they are also encountered with significant frequency in the adult population. These neoplastic processes can be of B-cell or T-cell derivation and are composed of immature precursors of either lineage.
D. Luca
semanticscholar +3 more sources
Pediatric Autoimmunity and Transplantation, 2019
The highest-resolution HLA typing is thought to provide the best opportunity for matching a patient with a donor in order to reduce the risks for graft-versus host disease (GVHD) and graft rejection Linkage disequilibrium is an important concept regarding HLA type associations, and can be used to help surmise which HLA alleles may be present ...
S. Pandey, T. Harville
semanticscholar +2 more sources
The highest-resolution HLA typing is thought to provide the best opportunity for matching a patient with a donor in order to reduce the risks for graft-versus host disease (GVHD) and graft rejection Linkage disequilibrium is an important concept regarding HLA type associations, and can be used to help surmise which HLA alleles may be present ...
S. Pandey, T. Harville
semanticscholar +2 more sources
Non-Hodgkin's Lymphoma in Childhood and Adolescence, 2019
B. Burkhardt, B. Wistinghausen
semanticscholar +2 more sources
B. Burkhardt, B. Wistinghausen
semanticscholar +2 more sources
Hematology/Oncology Clinics of North America, 2001
Recent advances in the unique clinicopathologic entity of lymphoblastic lymphoma (and its variants) are discussed in this article, which details the natural history, molecular biology, prognosis, and outcome with various chemotherapy regimens. Improved outcome with the newer intensive chemotherapy regimens and the role of modalities such as autologous ...
D A, Thomas, H M, Kantarjian
openaire +2 more sources
Recent advances in the unique clinicopathologic entity of lymphoblastic lymphoma (and its variants) are discussed in this article, which details the natural history, molecular biology, prognosis, and outcome with various chemotherapy regimens. Improved outcome with the newer intensive chemotherapy regimens and the role of modalities such as autologous ...
D A, Thomas, H M, Kantarjian
openaire +2 more sources
The Cancer Journal, 2012
Adult lymphoblastic lymphoma (LBL) is an aggressive form of non-Hodgkin lymphoma occurring in predominantly adolescent and young adult men. Lymphoblastic lymphoma is rare, accounting for 1% to 2% of all non-Hodgkin lymphomas and is of T-cell phenotype in 90% of cases.
Craig A, Portell, John W, Sweetenham
openaire +2 more sources
Adult lymphoblastic lymphoma (LBL) is an aggressive form of non-Hodgkin lymphoma occurring in predominantly adolescent and young adult men. Lymphoblastic lymphoma is rare, accounting for 1% to 2% of all non-Hodgkin lymphomas and is of T-cell phenotype in 90% of cases.
Craig A, Portell, John W, Sweetenham
openaire +2 more sources
British Journal of Haematology, 2019
Lymphoblastic lymphoma (LBL) is the second most common type of Non‐Hodgkin Lymphoma (NHL) in childhood and adolescence, accounting for 25–35% of all cases. The majority, 70–80%, is of T‐lymphoblastic origin while 20–25% arise from B lymphoblasts.
B. Burkhardt, M. Hermiston
semanticscholar +1 more source
Lymphoblastic lymphoma (LBL) is the second most common type of Non‐Hodgkin Lymphoma (NHL) in childhood and adolescence, accounting for 25–35% of all cases. The majority, 70–80%, is of T‐lymphoblastic origin while 20–25% arise from B lymphoblasts.
B. Burkhardt, M. Hermiston
semanticscholar +1 more source
Leukemia and Lymphoma, 2019
Chidamide, a novel histone deacetylase inhibitor, has exerted effects in T-cell tumors through various mechanisms. Seventeen patients with refractory or relapsed T-cell acute lymphoblastic lymphoma/leukemia (T-LBL/ALL) received Chidamide combined with ...
Wei-ping Guan +5 more
semanticscholar +1 more source
Chidamide, a novel histone deacetylase inhibitor, has exerted effects in T-cell tumors through various mechanisms. Seventeen patients with refractory or relapsed T-cell acute lymphoblastic lymphoma/leukemia (T-LBL/ALL) received Chidamide combined with ...
Wei-ping Guan +5 more
semanticscholar +1 more source
Pediatric Blood & Cancer, 2019
Hypersensitivity to pegaspargase is associated with inferior survival in pediatric patients with acute lymphoblastic leukemia and lymphoblastic lymphoma.
K. August +7 more
semanticscholar +1 more source
Hypersensitivity to pegaspargase is associated with inferior survival in pediatric patients with acute lymphoblastic leukemia and lymphoblastic lymphoma.
K. August +7 more
semanticscholar +1 more source
Lymphoblastic lymphoma in adults
Current Hematologic Malignancy Reports, 1996Understanding of the pathogenesis and biology of precursor T-cell and B-cell neoplasms has advanced significantly with the description of gene expression profiling studies, especially in T-cell disease. These studies have demonstrated leukemic arrest at various stages of thymocyte maturation, characterized by gene expression signatures with prognostic ...
openaire +2 more sources